Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Mphosph1 peptides and vaccines including the same

An amino acid, selected from the technology, applied in the field of cancer treatment, bioscience

Active Publication Date: 2014-04-16
ONCOTHERAPY SCI INC
View PDF29 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, previous studies failed to confirm whether these peptide fragments have the ability to induce CTL targeting tumor cells expressing MPHOSPH1 gene and HLA-A2 antigen

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Mphosph1 peptides and vaccines including the same
  • Mphosph1 peptides and vaccines including the same
  • Mphosph1 peptides and vaccines including the same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0444] Materials and methods

[0445] cell line

[0446] T2, HLA-A*0201-positive B-lymphoblastoid cell line, HLA-A*0206-positive B-lymphoblastoid cell line, HT1376, J82, COS7 and UM-UC3 were purchased from ATCC. MKN-45 was purchased from JCRB.

[0447] Candidate selection for peptides derived from MPHOSPH1

[0448] Using the binding prediction software "BIMAS" (http: / / www-bimas.cit.nih.gov / molbio / hla_bind) (Parker et al., J Immunol 1994,152(1):163-75; Kuzushima et al., Blood 2001, 98(6):1872-81) predicted 9- and 10-mer peptides derived from MPHOSPH1 (GenBank Accession No: EAW63006 (SEQ ID NO: 40)) that bind the HLA-A*0201 molecule. These peptides were synthesized by BioSynthesis (Lewisville, Texas) according to standard solid phase synthesis and purified by reverse phase high performance liquid chromatography (HPLC). The purity (>90%) and identity of the peptides were determined by analytical HPLC and mass spectrometry, respectively. Peptides were dissolved in dimet...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

As discussed in greater detail herein, isolated epitope peptides derived from MPHOSPH1 bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL) and thus are suitable for use in the context of cancer immunotherapy, more particularly cancer vaccines. The inventive peptides encompass both the above-mentioned MPHOSPH1-derived amino acid sequences and modified versions thereof, in which one, two, or several amino acids are substituted, deleted, inserted or added, provided such modified versions retain the requisite CTL inducibility of the original sequences. Further provided are polynucleotides encoding any of the aforementioned peptides as well as pharmaceutical agents or compositions that include any of the aforementioned peptides or polynucleotides. The peptides, polynucleotides, and pharmaceutical agents or compositions of this invention find particular utility in either or both of the treatment and prevention of cancers and tumors, including, for example, bladder cancer, breast cancer, cervical cancer, cholangiocellular carcinoma, CML, colorectal cancer, gastric cancer, NSCLC, lymphoma, osteosarcoma, prostate cancer, renal cancer and soft tissue tumor.

Description

technical field [0001] The present invention relates to the field of biological sciences, more specifically to the field of cancer treatment. Specifically, the present invention relates to novel peptides useful as cancer vaccines, and drugs for treating and / or preventing tumors. [0002] priority [0003] This application claims the benefit of US Provisional Application 61 / 522,991, filed August 12, 2011, which is hereby incorporated by reference in its entirety. Background technique [0004] It has been demonstrated that cytotoxic T lymphocytes (CTLs) can recognize epitope peptides derived from tumor-associated antigens (TAAs) appearing on major histocompatibility complex (MHC) class I molecules, and then kill tumor cells. Since the discovery of the melanoma antigen (MAGE) family, many other TAAs have been discovered mainly by immunological means (NPL1, Boon T, Int J Cancer 1993 May 8,54(2):177-80; NPL2, Boon T & van der Bruggen P, J Exp Med 1996 Mar 1, 183(3):725-9). So...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/09A61K38/00A61P35/00A61P43/00C07K7/06
CPCC12N5/0639C12Y306/04004A61K39/00A61K38/00A61K39/0011C12N9/93G01N2440/14C12N5/00G01N33/505G01N33/57407C12N2502/1114C12N9/14C12N5/10C07K14/4738A61P35/00A61P35/02A61P37/04A61P43/00A61K38/08C07K7/06C12N15/8509C12N2015/8518
Inventor 角田卓也大泽龙司吉村祥子渡边朝久中村佑辅
Owner ONCOTHERAPY SCI INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com